Destiny Pharma PLC
LSE:DEST
Destiny Pharma PLC
Common Shares Outstanding
Destiny Pharma PLC
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Destiny Pharma PLC
LSE:DEST
|
Common Shares Outstanding
£95.3m
|
CAGR 3-Years
17%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Common Shares Outstanding
$98.8m
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Common Shares Outstanding
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Common Shares Outstanding
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Common Shares Outstanding
£49.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Common Shares Outstanding
£66m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Destiny Pharma PLC's Common Shares Outstanding?
Common Shares Outstanding
95.3m
GBP
Based on the financial report for Dec 31, 2023, Destiny Pharma PLC's Common Shares Outstanding amounts to 95.3m GBP.
What is Destiny Pharma PLC's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
17%
Over the last year, the Common Shares Outstanding growth was 30%. The average annual Common Shares Outstanding growth rates for Destiny Pharma PLC have been 17% over the past three years , 17% over the past five years .